Acute and chronic citalopram treatment differently modulates rat exploratory behavior in the exploration box test: No evidence for increased anxiety or changes in the [3H]raclopride binding

Pharmacology

Volumn 58, Issue 2, 1999, Pages 59-69

  Matto, Vallo ^a   Allikmets, Lembit ^b  

^a UNIVERSITY OF TARTU   (Estonia)

^b NONE

Author keywords

3H Raclopride binding; Citalopram; Desipramine; Exploratory behavior, rat

Indexed keywords

CITALOPRAM; DESIPRAMINE; NEUROLEPTIC AGENT; RACLOPRIDE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRITIUM;

ANIMAL EXPERIMENT; ARTICLE; DOSE RESPONSE; DRUG BINDING; EXPLORATORY BEHAVIOR; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; NEOSTRIATUM; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT;

ADRENERGIC UPTAKE INHIBITORS; ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; CITALOPRAM; DESIPRAMINE; DOPAMINE ANTAGONISTS; EXPLORATORY BEHAVIOR; FEMALE; NEOSTRIATUM; RACLOPRIDE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; SALICYLAMIDES; SEROTONIN UPTAKE INHIBITORS;

EID: 0032921555     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028269     Document Type: Article

References (37)

1. Åsberg M, Mårtensson B: Serotonin selective antidepressant drugs: Past, present, future. Clin Neuropharmacol 1993:16(suppl 3):32-44.
2. Hyttel J, Amt J, Sanchez C: The pharmacology of citalopram. Rev Contemp Pharmacother 1995;6: 271-285.
3. Schweizer E, Rickels K, Uhlenhuth EH: Issues in the long term treatment of anxiety disorders; in Bloom FE, Kupfer DJ (eds): Psychopharmacology. The Fourth Generation of Progress. New York, Raven Press, 1995, pp 1349-1360.
4. Tyrer P, Tyrer J: Antidepressive drugs for treatment of anxiety disorders - and vice versa; in den Boer JA, Ad Sitsen JM (eds): Handbook of Depression and Anxiety. A Biological Approach. New York, Dekker, 1994, pp 497-514.
5. Finley PR: Selective serotonin reuptake inhibitors: Pharmacological profiles and potential therapeutic distinctions. Ann Pharmacother 1994;28:1359-1369.
6. Griebel G, Blanchard DC, Agnes RS, Blanchard RJ: Different modulation of antipredator defensive behaviour in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine. Psychopharmacology 1995:120:57-66.
7. Griebel G, Moreau J-L, Jenck F, Misslin R, Martin JR: Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents. Psychopharmacology 1994;113:463-470.
8. Matto V, Harro J, Allikmets L: The effects of cholecystokinin A and B receptor antagonists, devazepide and L 365260, on citalopram-induced decrease of exploratory behaviour in rat. J Physiol Pharmacol 1996;47:661-669.
9. Boyer WF, Feighner JP: Side effects of the selective serotonin re-uptake inhibitors; in Feighner JP, Boyer WP (eds): Selective Serotonin Re-Uptake Inhibitors. New York, Wiley, 1991, pp 133-152.
10. Chopin P, Briley M: Animal models of anxiety: The effect of compounds that modify 5-HT neurotransmission. Trends Pharmacol Sci 1987;8: 383-388.
11. Harro J, Oreland L, Vasar E, Bradwejn J: Impaired exploratory behaviour after DSP-4 treatment in rats: Implications for the increased anxiety after noradrenergic denervation. Eur Neuropsychopharmacol 1995;5: 447-455.
12. Kelley AE, Cador M, Stinus L: Exploration and its measurement; in Boulton AA, Baker GL, Greenshow AJ (eds): Neuromethods 13: Psychopharmacology. Clifton, Humana, 1989, pp 95-144.
13. Harro J: Measurement of exploratory behaviour in rodents; in Conn RA (ed): Methods in Neurosciences. San Diego, Academic Press, 1993, vol 14, pp 359-377.
14. Matto V, Harro J, Allikmets L: The effect of drugs acting on CCK receptors and rat free exploration in the exploration box. J Physiol Pharmacol 1997;48:239-251.
15. Otter M, Matto V, Sôukand R, Skrebuhhova T, Allikmets L, Harro J: Characterization of rat exploratory behaviour using the exploration box test. Methods Find Exp Clin Pharmacol 1997;19:683-691.
16. Otter M, Skrebuhhova T, Matto V, Harro J: Measurement of exploratory behaviour in rat; in O'Donoghue PN (ed): Welfare and Science. Proc 6th Symp Fed Eur Laboratory Animal Science Assoc. London, Royal Society of Medicine Press, 1997, in press.
17. Otter MH, Sôukand R, Oreland L, Harro J: Pharmacological validation of the exploration box: Preliminary studies. Pharmacol Toxicol 1995; 76(suppl 3):60.
18. 2 dopamine receptors in the rat brain. J Neural Transm 1997;104:515-524.
19. Leonard BE: The comparative pharmacological properties of selective serotonin reuptake inhibitors in animals; in Feighner JP, Boyer WF (eds): Selective Serotonin Reuptake Inhibitors: Advances in Basic Research and Clinical Practice, ed 2. Chichester, Wiley, 1996, pp 35-62.
20. 3H]Raclopride binding to brain tissue from subjects with schizophrenia: Methodological aspects. Neuropharmacology 1997;36:779-786.
21. 3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity. J Pharmacol Exp Ther 1989;250:696-706.
22. 2 receptors: Homogenate binding and autoradiographic studies. Neurochem Int 1997;30:277-290.
23. Lepiku M, Rinken A, Järv J, Fuxe K: Kinetic evidence for isomerization of the dopamine receptor-raclopride complex. Neurochem Int 1996;28:591-595.
24. Daniel WW: Biostatistics: A Foundation for Analysis in the Health Science. New York, Wiley, 1983.
25. Pellow S, File SE: Can anti-panic drugs antagonise the anxiety produced in the rat by drugs acting at the GABA-benzodiazepine receptor complex? Neuropsychobiology 1987;17:60-65.
26. Bodnoff SH, Suranyi-Cadotte B, Aitken DH, Quirion R, Meaney MJ: The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology 1988;95:298-302.
27. Bodnoff SH, Suranyi-Cadotte B, Quirion R, Meaney MJ: A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology 1989;97:277-279.
28. Lightowler S, Kennett GA, Williamson IJR, Blackburn TP, Tulloch IF: Anxiolytic-like effect of paroxetine in a rat social interaction test. Pharmacol Biochem Behav 1994;49: 281-285.
29. Fontana DJ, Carbary TJ, Commissans RL: Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat. Psychopharmacology 1989;98:157-162.
30. Fontana DJ, Commissaris RL: Effects of acute and chronic imipramine administration on conflict behavior in the rat: A potential 'animal model' for the study of panic disorder? Psychopharmacology 1988;95: 147-150.
31. B receptor antagonists in ethological and conditioned animal screens for anxiolytic drugs. Psychopharmacology 1995;121:109-117.
32. Arnt J, Overo KF, Hyttel J, Olsen R: Changes in rat dopamine-and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram. Psychopharmacology 1984;84:457-465.
33. Maj J, Rogoz Z, Skuza G, Kolodziejczyk K: Antidepressant effects of pramipexole, a novel dopamine receptor agonist. J Neural Transm 1997;104:525-533.
34. Kivastik T, Vuorikallas K, Piepponen TP, Zharkovsky A, Ahtee L: Morphine-and cocaine-induced conditioned place preference: Effect of quinpirole and preclamole. Pharmacol Biochem Behav 1996;54:371-375.
35. Allikmets L, Matto V, Skrebuhhova T: The effect of antidepressants on apomorphine-induced aggressive behavior. Pharmacol Toxicol 1997; 80(suppl 1):14.
36. Allikmets LH, Vasar E: Sensitization of male rats to aggressive behavior. Zh Vyssh Nerv Deiat 1982; 32:130-135.
37. Young KA, Zavodny R, Hicks PB: Effects of serotoninergic agents on apomorphine-induced locomotor activity. Psychopharmacology 1993;110:97-102.